Research | OneLook Acronym Finder |
Serial Number | 86614412 |
Registration Number | 6295368 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Jonathan A. Hyman |
Attorney Docket Number | RJNK082.005T |
Law Office Assigned | M10 |
Employee Name | KHOURI, SANI PHILIPPE |
2015-04-29 | Application Filed |
2017-11-21 | Published for Opposition |
2018-01-16 | Location: INTENT TO USE SECTION |
2019-06-13 | Status: Live/Pending |
2019-06-15 | Transaction Date |
2021-03-16 | Trademark Registered |
Owner: | EKOS Corporation |
Address | 11911 North Creek Parkway South Bothell DE 98011 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 41 |
U.S. Codes: | 100,101,107 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical and medicinal preparations and substances for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages and hematoma; pharmaceutical and medicinal preparations and substances, namely, lysing solutions and reagents, and hemolytic lysing solutions and reagents; chemical reagents for medical therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, and intracranial hemorrhages, cerebral hemorrages, and hematoma; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and medically activate drugs |
GS0091 | Computer hardware and software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; computers; computer hardware and software for medical imaging apparatus; computer installations, apparatus and instruments, namely, computer software and associated computer hardware for use in collecting, storing, managing, processing, communicating and reporting of data obtained from medical devices, medical related devices and input devices to which the hardware interconnects; computer imaging systems comprising computer hardware and software for medical imaging apparatus; computer software and computer programs in the field of ultrasounds and medical devices for controlling and operating medical devices and ultrasound apparatus; computer software for use in the medical and pharmaceutical fields for use in the operation of medical devices and ultrasound equipment; computer software for use in medical devices for processing, analyzing and displaying images and reports from these medical devices; computer software and computer programs providing information to medical professionals and patients; computer hardware; electric and electronic control systems for controlling medical apparatus and instruments; electric and electronic control systems for controlling apparatus for generating and transmitting ultrasound; data processing apparatus and computers for controlling medical apparatus and instruments; data processing apparatus and computers for controlling apparatus for generating and transmitting ultrasound; computer software for controlling medical apparatus and instruments; computer software for controlling apparatus for generating and transmitting ultrasound; stands for computer equipment; medical software for processing and displaying images on ultrasound medical imaging apparatus; medical imaging software that records, monitors and analyses data using an ultrasound imaging probe; medical workstation comprised of computer hardware and software for gathering and transmitting patient image data for use during surgical procedures; software for processing digital images of the anatomy for diagnosis and treatment; software for medical imaging; equipment for scientific research, namely, ultrasound imaging systems comprising ultrasound scanners, ultrasound imaging devices, and ancillary equipment sold as a unit; computer software for use in relation to ultrasound imaging and scanning; parts and fittings for all the aforesaid goods |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2015-05-02 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-05-11 | 2 NWOS I:Incoming Correspondence |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2015-05-26 | 3 PARI I:Incoming Correspondence |
ASSIGNED TO LIE | 2015-06-01 | 4 ALIE A:Allowance for Publication |
APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2015-06-08 | 5 AMPX O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2015-07-08 | 6 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2015-07-15 | 7 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2015-07-15 | 8 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2015-07-15 | 9 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-01-15 | 10 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-01-15 | 11 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-01-16 | 12 TEME I:Incoming Correspondence |
SUSPENSION LETTER WRITTEN | 2016-02-02 | 13 CNSL R:Renewal |
LETTER OF SUSPENSION E-MAILED | 2016-02-02 | 14 GNSL S: |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2016-02-02 | 15 GNS3 O:Outgoing Correspondence |
LIE CHECKED SUSP - TO ATTY FOR ACTION | 2016-08-08 | 16 RCCK S: |
SUSPENSION INQUIRY WRITTEN | 2016-08-29 | 17 CNSI R:Renewal |
INQUIRY TO SUSPENSION E-MAILED | 2016-08-29 | 18 GNSI S: |
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2016-08-29 | 19 GNS2 O:Outgoing Correspondence |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2017-02-23 | 20 ERSI I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-03-08 | 21 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-03-08 | 22 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2017-03-29 | 23 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-03-29 | 24 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-03-29 | 25 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-09-18 | 26 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-09-21 | 27 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-09-21 | 28 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-10-12 | 29 CNSA P: |
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2017-10-13 | 30 ERRR O:Outgoing Correspondence |
ELECTRONIC RECORD REVIEW COMPLETE | 2017-10-19 | 31 FIXD O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-11-01 | 32 NONP E:E-Mail |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2017-11-06 | 33 EPPA I:Incoming Correspondence |
ASSIGNED TO PETITION STAFF | 2017-11-20 | 34 APET A:Allowance for Publication |
PUBLISHED FOR OPPOSITION | 2017-11-21 | 35 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-11-21 | 36 NPUB E:E-Mail |
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2017-11-22 | 37 CHPB I:Incoming Correspondence |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-01-16 | 38 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-07-12 | 39 EEXT I:Incoming Correspondence |
EXTENSION 1 FILED | 2018-07-12 | 40 EXT1 S: |
EXTENSION 1 GRANTED | 2018-07-12 | 41 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-07-14 | 42 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2018-10-23 | 43 EEXT I:Incoming Correspondence |
EXTENSION 2 FILED | 2018-10-23 | 44 EXT2 S: |
EXTENSION 2 GRANTED | 2018-10-23 | 45 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2018-10-25 | 46 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2019-06-13 | 47 EEXT I:Incoming Correspondence |
EXTENSION 3 FILED | 2019-06-13 | 48 EXT3 S: |
EXTENSION 3 GRANTED | 2019-06-13 | 49 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-06-15 | 50 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-01-15 | 51 EEXT I:Incoming Correspondence |
EXTENSION 4 FILED | 2020-01-15 | 52 EXT4 S: |
EXTENSION 4 GRANTED | 2020-01-15 | 53 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-17 | 54 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2020-07-06 | 55 EEXT I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-07-23 | 56 AITU A:Allowance for Publication |
EXTENSION 5 FILED | 2020-07-06 | 57 EXT5 S: |
EXTENSION 5 GRANTED | 2020-07-27 | 58 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-28 | 59 EXRA E:E-Mail |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-10-26 | 60 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-10-26 | 61 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-10-26 | 62 ARAA I:Incoming Correspondence |
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2020-10-26 | 63 EWAF I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-10-26 | 64 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-10-26 | 65 CHAN I:Incoming Correspondence |
TEAS STATEMENT OF USE RECEIVED | 2021-01-18 | 66 EISU I:Incoming Correspondence |
USE AMENDMENT FILED | 2021-01-18 | 67 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2021-01-22 | 68 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2021-02-08 | 69 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2021-02-09 | 70 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2021-03-16 | 71 R.PR A:Allowance for Publication |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-04-21 | 72 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-04-21 | 73 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-04-21 | 74 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-04-21 | 75 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-04-21 | 76 CHAN I:Incoming Correspondence |
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2022-01-26 | 77 ASGN I:Incoming Correspondence |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-03-16 | 78 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-03-16 | 79 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-03-16 | 80 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-03-16 | 81 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-03-16 | 82 CHAN I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.